Vidac is a clinical stage innovative biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncology and dermatology ailments. We at Vidac are passionate about transforming breakthrough science into innovative therapies to address major unmet medical needs. Our breakthrough technology targets the VDAC/HK2 system that is unique to malignant cells. Modulating this target leads to selective apoptosis of cancer cells without affecting the surrounding healthy tissue, thus holds the promise of delivering first-in-class drugs that are both efficacious and well tolerated by patients.
Looking for a particular Vidac Pharma employee's phone or email?
The Vidac Pharma annual revenue was $4 million in 2026.
Shuki Cohen is the CFO of Vidac Pharma.
4 people are employed at Vidac Pharma.
The NAICS codes for Vidac Pharma are [541, 325, 3254, 32541, 54, 325413, 32].
The SIC codes for Vidac Pharma are [873, 28, 283, 87].